-
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart I – Nonconforming Product (§820.90). Form 483 observations and Warning Letters 2017–2025. -
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart J – Corrective and Preventive Action (§820.100 CAPA). Form 483 observations and Warning Letters 2017–2025. -
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart K – Labeling and Packaging Control (§820.120 Device labeling, §820.130 Device packaging). Form 483 observations and Warning Letters 2017–2025. -
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart L – Handling, Storage, Distribution, and Installation (§820.140, §820.150, §820.160, §820.170). Form 483 observations and Warning Letters 2017–2025. -
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart M – Records (§820.180 General requirements, §820.181 Device master record, §820.184 Device history record, §820.186 Quality system record, §820.198 Complaint files). Form 483 observations and Warning Letters 2017–2025. -
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart N – Servicing (§820.200) and Subpart O – Statistical Techniques (§820.250). Form 483 observations and Warning Letters 2017–2025.
ComplyFDA delivers authoritative compliance intelligence for pharmaceuticals, medical devices, biologics, and combination products, giving your team the clarity needed to strengthen inspection readiness, evaluate compliance risks, and support continuous quality improvement.
services.
get in touch.
© 2012 - 2026 • Avada is a Website Builder for WordPress and eCommerce • All Rights Reserved • Developed by ThemeFusion
